Business Valuation: Independent Analysis Where the Numbers Have Consequences

Valuation involves judgment across multiple dimensions including methodology selection, comparable company selection, financial normalization, projection assumptions, discount rates, and terminal value treatment. Different analysts making different but defensible choices will produce different conclusions within a range. The range is usually not as wide as it might seem because the major drivers of value (business performance, market dynamics, comparable transactions) constrain the possible conclusions. But the range exists and is a feature of the analysis rather than a flaw. Valuations that present themselves as the single correct answer misrepresent the nature of the exercise. Defensible valuations explain the range and the factors that move the value within it.

Independent valuations are required in multiple specific circumstances under Indian law. Share transactions involving unlisted shares need valuations under Income Tax Act Section 56(2) to avoid tax implications. Cross-border transactions require valuations that satisfy FEMA pricing guidelines. Public company transactions under SEBI Takeover Regulations and Delisting Regulations have specific valuation requirements. Share issuances under the Companies Act require specific valuation approaches in some circumstances. Insolvency proceedings under IBC require liquidation and fair value estimates by registered valuers. Purchase price allocations for financial reporting under Ind AS require supporting valuations. Beyond regulatory requirements, boards often commission independent valuations for fairness opinions on significant transactions. The specific requirement depends on the transaction type and regulatory context.

Enterprise value represents the value of the entire business, including both equity and debt. It is the value that would be required to acquire the entire business free of financial liabilities. Equity value represents the value available to equity holders, calculated as enterprise value minus net debt and other adjustments. The distinction matters because deal economics depend on whether transactions are structured on an enterprise value or equity value basis, and the adjustments for debt, cash, working capital, and similar items can be significant. Valuation reports should clearly distinguish between enterprise value and equity value, and should present the reconciliation between them. Reports that confuse the two concepts create ambiguity that affects negotiation and deal documentation.

DCF (discounted cash flow) valuation estimates value based on projected future cash flows discounted to present value. It is driven by the specific characteristics of the business being valued and the projections developed for the analysis. Comparable company valuation estimates value based on multiples observed in trading prices of similar public companies or in comparable M&A transactions. It is driven by market pricing of comparable businesses rather than intrinsic cash flow analysis. The two approaches provide different perspectives: DCF captures business-specific factors but depends on projections that may not materialize. Comparable company analysis captures market pricing but depends on the comparability of the selected companies. Most valuations use both approaches with weighting that reflects the strengths and weaknesses of each for the specific business.

A fairness opinion is an independent professional opinion on whether the financial terms of a proposed transaction are fair to a specific party or group of parties from a financial point of view. It is typically commissioned by the board of directors of a company considering a significant transaction, to support the board's fiduciary duty analysis. Fairness opinions do not endorse the strategic merits of a transaction, the fairness of non-financial terms, or the legal aspects of the deal. They address specifically whether the financial consideration is fair given the analysis conducted. Fairness opinions are particularly important in transactions involving related parties, going-private transactions, and other situations where the board needs independent analysis to support its decision-making.

Regulatory valuations must satisfy the specific requirements of the applicable regulatory framework, which may differ from pure commercial valuation methodology. Income Tax Act valuations for unlisted shares follow prescribed rules that may produce values different from commercial analysis. FEMA valuations have pricing guidelines that create floors and ceilings. SEBI valuations for public company transactions have specific methodology requirements. Commercial valuations for negotiation purposes may produce different numbers than the regulatory valuations, and both may be legitimate. Effective valuation practice understands the specific regulatory requirements and produces documentation that satisfies them while capturing commercial insight separately where appropriate. Valuations that ignore the regulatory requirements create exposure regardless of their commercial accuracy.

A focused valuation for a specific purpose typically takes 3 to 6 weeks from kickoff to final report, depending on the complexity of the business, the availability of information, and the depth of analysis required. Complex valuations involving multiple business segments, cross-border considerations, or litigation-grade documentation may take longer. The timeline is driven primarily by business understanding and analytical depth rather than report production. Valuations that are compressed into very short timelines typically sacrifice depth of analysis, which affects the defensibility of the conclusions. Parties who need defensible valuations should allow sufficient time for the analytical work that produces defensibility.